PopVax, a biotech startup in Hyderabad, will design and manufacture custom mRNA cancer vaccines, each built from a patient's own tumour data.
Turnaround from tumour sequencing to a shippable vaccine is estimated at 8 to 10 weeks. The service, offered through its RNA Foundry, costs an estimated $300,000 (about Rs 2.7 crore) per patient, so it is mainly open to wealthy patients.
It is experimental, not an approved treatment or a running trial, and PopVax currently has 100 patient slots.
Sachin Tendulkar has taken a non-controlling stake in Recykal, the Indian waste management technology firm.
His investment extends the $23 million round Recykal closed in June. The company will use the money to strengthen its tech platform, expand its Deposit Return System for packaging waste, and grow internationally.
Recykal's goal is to change the habits of a billion people, and Tendulkar said he was drawn in by how technology tackled a daily problem.
SpaceX plans to invest more than $74 billion across two AI supercomputing campuses, one in Texas and one in Arizona.
The Texas facility at Starbase, estimated at over $24 billion, will sit on about 444 acres near Brownsville and generate its own power off the public grid. The project has already created over 3,000 construction jobs.
The roughly $50 billion Arizona campus in Cochise County could scale up to 6 gigawatts, though it still needs county approvals. The Starbase city commission will weigh a property tax break for the Texas project on December 9.
